Once-weekly semaglutide doubles the five-year risk of nonarteritic anterior ischemic optic neuropathy in a Danish cohort of 424,152 persons with type 2 diabetes

Once-weekly semaglutide doubles the five-year risk of nonarteritic anterior ischemic optic neuropathy in a Danish cohort of 424,152 persons with type 2 diabetes

Abstract Background Nonarteritic anterior ischemic optic neuropathy (NAION) is an untreatable condition often causing severe and irreversible visual loss in the affected eye. As it has recently been implied that the use of semaglutide associates with NAION, the aim of the present study was to evalua...

Full description

Saved in:
Bibliographic Details
Main Authors: Jakob Grauslund, Andreas Abou Taha, Laleh Dehghani Molander, Ryo Kawasaki, Sören Möller, Kurt Højlund, Lonny Stokholm
Format: Article
Language:English
Published: BMC 2024-12-01
Series:International Journal of Retina and Vitreous
Subjects:
Cohort study
Nonarteritic anterior ischemic optic neuropathy
Registry based
Semaglutide
Type 2 diabetes
Online Access:https://doi.org/10.1186/s40942-024-00620-x
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items